Home › Compare › IPIX vs NNN

IPIX vs NNN: Dividend Comparison 2026

IPIX yields 285714.29% · NNN yields 5.68%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 IPIX wins by $1.734986541242196e+31M in total portfolio value
10 years
IPIX
IPIX
● Live price
285714.29%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1.734986541242196e+31M
Annual income
$17,337,928,197,276,910,000,000,000,000,000,000,000.00
Full IPIX calculator →
NNN
NNN REIT Inc.
● Live price
5.68%
Share price
$41.89
Annual div
$2.38
5Y div CAGR
8.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$25.6K
Annual income
$2,637.42
Full NNN calculator →

Portfolio growth — IPIX vs NNN

📍 IPIX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodIPIXNNN
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, IPIX + NNN cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
IPIX pays
NNN pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

IPIX
Annual income on $10K today (after 15% tax)
$24,285,714.29/yr
After 10yr DRIP, annual income (after tax)
$14,737,238,967,685,373,000,000,000,000,000,000,000.00/yr
NNN
Annual income on $10K today (after 15% tax)
$482.93/yr
After 10yr DRIP, annual income (after tax)
$2,241.81/yr
At 15% tax rate, IPIX beats the other by $14,737,238,967,685,373,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of IPIX + NNN for your $10,000?

IPIX: 50%NNN: 50%
100% NNN50/50100% IPIX
Portfolio after 10yr
$8.67493270621098e+30M
Annual income
$8,668,964,098,638,455,000,000,000,000,000,000,000.00/yr
Blended yield
99.93%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on NNN right now

IPIX
No analyst data
Altman Z
-28.5
Piotroski
2/9
NNN
Analyst Ratings
10
Buy
15
Hold
4
Sell
Consensus: Hold
Price Target
$44.93
+7.3% upside vs current
Range: $43.00 — $48.50
Altman Z
1.1
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

IPIX buys
0
NNN buys
0
No recent congressional trades found for IPIX or NNN in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricIPIXNNN
Forward yield285714.29% ✓5.68%
Annual dividend / share$2.00$2.38 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%8.6% ✓
Portfolio after 10y$1.734986541242196e+31M$25.6K ✓
Annual income after 10y$17,337,928,197,276,910,000,000,000,000,000,000,000.00 ✓$2,637.42
Total dividends collected$1.734908400352195e+31M$13.7K ✓
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: IPIX vs NNN ($10,000, DRIP)

YearIPIX PortfolioIPIX Income/yrNNN PortfolioNNN Income/yrGap
1← crossover$28,582,129$28,571,428.57$10,737$617.02+$28.57M → IPIX
2$76,351,353,429$76,320,770,551.21$11,577$710.93+$76351.34M → IPIX
3$190,619,493,207,524$190,537,797,259,355.30$12,538$822.59+$190619493.19M → IPIX
4$444,781,927,427,195,200$444,577,964,569,463,100.00$13,645$956.06+$444781927427.18M → IPIX
5$969,967,353,346,567,200,000$969,491,436,684,220,000,000.00$14,925$1,116.51+$969967353346567.13M → IPIX
6$1,976,961,629,315,093,000,000,000$1,975,923,764,247,012,300,000,000.00$16,415$1,310.57+$1976961629315092992.00M → IPIX
7$3,765,923,944,594,039,000,000,000,000$3,763,808,595,650,671,000,000,000,000.00$18,158$1,546.77+$3.765923944594039e+21M → IPIX
8$6,704,681,437,057,684,000,000,000,000,000$6,700,651,898,436,968,000,000,000,000,000.00$20,213$1,836.20+$6.704681437057683e+24M → IPIX
9$11,156,275,836,497,016,000,000,000,000,000,000$11,149,101,827,359,364,000,000,000,000,000,000.00$22,649$2,193.37+$1.1156275836497015e+28M → IPIX
10$17,349,865,412,421,960,000,000,000,000,000,000,000$17,337,928,197,276,910,000,000,000,000,000,000,000.00$25,558$2,637.42+$1.734986541242196e+31M → IPIX

IPIX vs NNN: Complete Analysis 2026

IPIX — Stock

Innovation Pharmaceuticals Inc., a clinical stage biopharmaceutical company, develops small molecule therapies to treat inflammatory diseases, cancer, dermatology, and anti- infective. Its lead drug candidate is Brilacidin, a therapeutic for the treatment of oral mucositis, inflammatory bowel disease, acute bacterial skin and skin structure infection, and COVID-19. The company is also developing Kevetrin, an anti-cancer compound for treating ovarian cancer. It has a license agreement with Alfasigma S.p.A.; and collaborative research agreement with Fox Chase Chemical Diversity Center, Inc. The company was formerly known as Cellceutix Corporation and changed its name to Innovation Pharmaceuticals Inc. in June 2017. Innovation Pharmaceuticals Inc. was incorporated in 2005 and is headquartered in Wakefield, Massachusetts.

Full IPIX Calculator →

NNN — REIT

National Retail Properties invests primarily in high-quality retail properties subject generally to long-term, net leases. As of September 30, 2020, the company owned 3,114 properties in 48 states with a gross leasable area of approximately 32.4 million square feet and with a weighted average remaining lease term of 10.7 years.

Full NNN Calculator →
📬

Get this IPIX vs NNN comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

IPIX vs SCHDIPIX vs JEPIIPIX vs OIPIX vs KOIPIX vs MAINIPIX vs ADCIPIX vs EPRTIPIX vs FCPT

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.